, Tracking Stock Market Picks
Enter Symbol:
Medicis Pharmaceutical Corporation (MRX) [hlAlert]

up 26.41 %

Medicis Pharmaceutical Corporation (MRX) rated Buy with price target $44 by Deutsche Bank

Posted on: Thursday,  Apr 5, 2012  3:25 PM ET by Deutsche Bank

Deutsche Bank rated Buy Medicis Pharmaceutical Corporation (NYSE: MRX) on 04/05/2012. Previously Deutsche Bank rated Buy Medicis Pharmaceutical Corporation (NYSE: MRX) on
04/07/2011., when the stock price was $34.79. Since then, Medicis Pharmaceutical Corporation has gained 26.42% as of 12/10/2012's recent price of $43.98.
If you would have followed the previous Deutsche Bank's recommendation on MRX, you would have gained 26.41% of your investment in 613 days.

Medicis Pharmaceutical Corporation (Medicis) is an independent specialty pharmaceutical company focused primarily on helping patients attain a healthy and youthful appearance and self-image through the development and marketing in the United States of products for the treatment of dermatological, aesthetic and podiatric conditions. It also markets products in Canada for the treatment of dermatological and aesthetic conditions. It offers a range of products addressing various conditions or aesthetic improvements, including facial wrinkles, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, skin and skin-structure infections, seborrheic dermatitis and cosmesis. It offers 18 branded products, including PERLANE (hyaluronic acid), RESTYLANE (hyaluronic acid), SOLODYN (minocycline HCl, USP), TRIAZ (benzoyl peroxide), VANOS (fluocinonide) Cream 0.1%, and ZIANA (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel. On July 1, 2008, the Company acquired LipoSonix, Inc.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/5/2012 3:25 PM Buy
39.29 44.00
as of 12/31/2012
1 Week   
1 Month up  1.68 %
3 Months up  1.64 %
1 YTD up  32.27 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/7/2011 12:25 PM Buy
34.79 40.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy